The company maintains a conservative capital structure with a negligible debt-to-equity ratio of 0.01 and total debt of only $407K as of 2026Q1.
| Total Current Assets | 42.59M | 45.89M | 56.74M | 49.53M | 53.24M | 31.25M | 25.17M | 34M | 31.9M | 17.89M | 16.76M | 8.57M | 5.84M |
| Cash & Short-Term Investments | 18.33M | 22.08M | 22.06M | 23.15M | 25.52M | 14.52M | 14.91M | 15.49M | 15.38M | 11.19M | 11.5M | 5.07M | 4.54M |
| Cash Only | 18.33M | 22.08M | 22.06M | 23.15M | 25.52M | 14.52M | 14.91M | 8.1M | 12.48M | 10.09M | 5.04M | 5.07M | 4.54M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.39M | 2.89M | 1.1M | 6.46M | 0 | 0 |
| Accounts Receivable | 3.58M | 6.04M | 19.73M | 10.64M | 17.3M | 12.13M | 3.78M | 14.01M | 13.15M | 4.96M | 3.1M | 2.07M | 407.59K |
| Days Sales Outstanding | 127.88 | 80.23 | 172.26 | 159.21 | 141.79 | 163.72 | 143.91 | 187.58 | 181.57 | 87.9 | 76.36 | 73.6 | 25.61 |
| Inventory | 16.5M | 14.56M | 10.1M | 11.86M | 3.5M | 1.76M | 4.43M | 3M | 1.63M | 1.17M | 1.25M | 998.86K | 844.07K |
| Days Inventory Outstanding | 376.33 | 340.41 | 212.1 | 418.49 | 85.74 | 63.86 | 373.35 | 112.71 | 62.47 | 62.99 | 92.25 | 98.57 | 149.94 |
| Other Current Assets | 1.71M | 1.68M | 1.51M | 888K | 660K | 268K | 0 | 0 | 0 | 0 | 0 | 310K | 0 |
| Total Non-Current Assets | 8.96M | 7.15M | 5.43M | 4.18M | 3.49M | 995K | 2.84M | 2.92M | 1.35M | 948.47K | 2.19M | 1.07M | 1.1M |
| Property, Plant & Equipment | 2.7M | 2.43M | 2.58M | 1.24M | 1.24M | 774K | 2.43M | 2.48M | 891.03K | 394.08K | 433.41K | 320.7K | 260.5K |
| Fixed Asset Turnover | 7.87x | 11.32x | 16.22x | 19.71x | 35.94x | 34.94x | 3.94x | 10.98x | 29.66x | 52.24x | 34.17x | 32.03x | 22.30x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 50K | 146K | 338K | 337.35K | 433.74K | 530.12K | 626.51K | 722.89K | 819.28K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.1M | 0 | 0 |
| Other Non-Current Assets | 566K | 640K | 652K | 804K | 492K | 75K | 69K | 101.56K | 24.27K | 24.27K | 24.27K | 24.27K | 24.27K |
| Total Assets | 51.55M | 53.04M | 62.16M | 53.71M | 56.73M | 32.24M | 28.01M | 36.92M | 33.25M | 18.84M | 18.95M | 9.64M | 6.94M |
| Asset Turnover | 0.41x | 0.52x | 0.67x | 0.45x | 0.78x | 0.84x | 0.34x | 0.74x | 0.79x | 1.09x | 0.78x | 1.07x | 0.84x |
| Asset Growth % | -30.5% | -14.68% | 15.74% | -5.33% | 75.98% | 15.1% | -24.14% | 11.05% | 76.54% | -0.59% | 96.62% | 38.79% | - |
| Total Current Liabilities | 5.86M | 4.72M | 5.88M | 4.21M | 7.7M | 5.96M | 4.86M | 6.47M | 6.02M | 7.08M | 3.66M | 3.67M | 2.75M |
| Accounts Payable | 4.69M | 3.34M | 4.81M | 2.79M | 5.52M | 4.06M | 0 | 0 | 5.17M | 4.07M | 2.76M | 2.31M | 1.08M |
| Days Payables Outstanding | 123.72 | 78.14 | 101.06 | 98.54 | 135.21 | 147.32 | - | - | 198.15 | 218.74 | 203.06 | 227.71 | 192.03 |
| Short-Term Debt | 267K | 262K | 0 | 0 | 0 | 51K | 0 | 0 | 0 | 0 | 0 | 422.7K | 375K |
| Deferred Revenue (Current) | 2.01M | 842K | 541K | 657K | 693K | 1.17M | 1.49M | 1.19M | 722.02K | 652.24K | 853.8K | 890.23K | 1.25M |
| Other Current Liabilities | 262K | 275K | 329K | 538K | 403K | 508K | 3.06M | 4.97M | 136.22K | 146.72K | 40.48K | 48.36K | 47.61K |
| Current Ratio | 7.27x | 9.72x | 9.64x | 11.76x | 6.92x | 5.24x | 5.18x | 5.26x | 5.30x | 2.53x | 4.58x | 2.34x | 2.12x |
| Quick Ratio | 4.45x | 6.63x | 7.93x | 8.94x | 6.46x | 4.94x | 4.27x | 4.79x | 5.03x | 2.36x | 4.24x | 2.06x | 1.81x |
| Cash Conversion Cycle | 380.48 | 342.5 | 283.3 | 479.15 | 92.32 | 80.26 | - | - | 45.89 | -67.85 | -34.45 | -55.54 | -16.49 |
| Total Non-Current Liabilities | 144K | 219K | 453K | 656K | 969K | 262K | 1.66M | 2.45M | 766.73K | 73.08K | 16.25K | 45.79K | 51K |
| Long-Term Debt | 0 | 209K | 0 | 0 | 0 | 0 | 267K | 0 | 0 | 2.21M | 0 | 0 | 0 |
| Capital Lease Obligations | 969K | 209K | 398K | 596K | 830K | 0 | 812K | 1.12M | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.43M | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | -209K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 6M | 4.94M | 6.34M | 4.87M | 8.67M | 6.22M | 6.51M | 8.92M | 6.79M | 7.15M | 3.67M | 3.71M | 2.8M |
| Total Debt | 407K | 680K | 602K | 783K | 1.02M | 225K | 1.38M | 1.43M | 0 | 2.21M | 0 | 422.7K | 375K |
| Net Debt | -17.92M | -21.4M | -21.45M | -22.36M | -24.5M | -14.29M | -13.53M | -6.68M | -12.48M | -7.87M | -5.04M | -4.64M | -4.16M |
| Debt / Equity | 0.01x | 0.01x | 0.01x | 0.02x | 0.02x | 0.01x | 0.06x | 0.05x | - | 0.19x | - | 0.07x | 0.09x |
| Debt / EBITDA | -0.03x | - | 0.07x | 9.91x | 0.07x | 0.05x | - | - | - | - | - | 4.48x | - |
| Net Debt / EBITDA | 1.54x | - | -2.52x | -283.10x | -1.60x | -3.02x | - | - | - | - | - | -49.21x | - |
| Interest Coverage | - | - | - | - | 7415.50x | 4121.00x | -487.29x | - | -11.91x | -52.87x | -14.84x | -12.34x | -183.70x |
| Total Equity | 45.54M | 48.1M | 55.83M | 48.84M | 48.07M | 26.02M | 21.5M | 28M | 26.46M | 11.68M | 15.27M | 5.92M | 4.14M |
| Equity Growth % | -34.98% | -13.84% | 14.3% | 1.61% | 84.77% | 21.02% | -23.23% | 5.83% | 126.54% | -23.53% | 157.94% | 43.1% | - |
| Book Value per Share | 2.77 | 2.95 | 3.41 | 3.00 | 2.89 | 1.58 | 1.31 | 1.72 | 1.87 | 0.88 | 1.27 | 0.55 | 0.42 |
| Total Shareholders' Equity | 45.54M | 48.1M | 55.83M | 48.84M | 48.07M | 26.02M | 21.5M | 28M | 26.46M | 11.68M | 15.27M | 5.92M | 4.14M |
| Common Stock | 169K | 169K | 169K | 169K | 169K | 167K | 166K | 165.4K | 161.46K | 135.22K | 135.46K | 428 | 408 |
| Retained Earnings | 3.09M | 5.71M | 13.43M | 6.79M | 6.3M | -17.94M | -22.06M | -15.23M | -13.53M | -11.5M | -7.79M | -7.45M | -7.21M |
| Treasury Stock | -3.88M | -3.88M | -3.57M | -3.52M | -3.43M | -325K | -310K | -252.57K | -133.82K | -133.82K | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -858.01K | -514.13K | -587.17K | -669.86K | -494.76K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales cycle and reimbursement
According to recent financial statements, Sensus Healthcare's total assets have declined from $62.2M in 2024Q4 to $51.5M in 2026Q1, signaling a contraction in the company's resource base as the business struggles to maintain its historical scale during a period of significant revenue volatility.
The reduction in total assets appears to be driven by a combination of declining cash reserves and lower working capital requirements as sales volume wanes. This trend suggests that the company is currently in a defensive posture, prioritizing the preservation of its remaining asset base over aggressive expansion or investment.
Based on reported figures, Sensus Healthcare maintains a robust liquidity position with $18.3M in cash and a current ratio of 7.27 as of 2026Q1, providing a significant buffer against ongoing operational losses and the inherent lumpiness of its capital equipment sales cycle.
The exceptionally high current ratio indicates that the company is not facing immediate solvency risks, despite the recent deterioration in operating performance. Investors should monitor whether this liquidity is deployed effectively to stabilize the sales funnel or if it will be gradually eroded by persistent cash burn.
As reported in recent SEC filings, Sensus Healthcare maintains a negligible debt-to-equity ratio of 0.01, with total debt standing at only $407K in 2026Q1, reflecting a highly conservative capital structure that avoids the risks associated with interest-bearing obligations in a volatile revenue environment.
The company's reliance on equity rather than debt financing suggests a strategic preference for financial independence, which is prudent given the current lack of consistent profitability. This lack of leverage provides the firm with significant optionality to navigate potential industry downturns without the pressure of debt service requirements.
Based on the company's balance sheet data, total equity has decreased from $55.8M in 2024Q4 to $45.5M in 2026Q1, a trend that appears to be driven by the accumulation of operating losses and the subsequent impact on retained earnings over the last several quarters.
The decline in retained earnings from $13.4M to $3.1M over the same period highlights the direct impact of negative net income on the company's book value. This erosion warrants further investigation into the company's ability to reverse its current profitability trajectory before shareholder value is further impaired.
Quick answers to the most common questions about buying SRTS stock.
As of 2025, Sensus Healthcare, Inc. (SRTS) had total assets of $53.0M including $45.9M in current assets.
Sensus Healthcare, Inc. (SRTS) carries total debt of $0.7M, offset by $22.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Sensus Healthcare, Inc. (SRTS) has total shareholders' equity (book value) of $48.1M ($2.95 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Sensus Healthcare, Inc. (SRTS) reported a current ratio of 9.72x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.